RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Raw

GILEAD SCIENCES, INC.GILD

Market cap
$157.1B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Product sales--------21,67722,11924,35527,00826,98226,93428,610
Royalty, contract and other revenues--------450330334297299182144
Total revenues--------22,12722,44924,68927,30527,28127,11628,754
Cost of goods sold--------4,8534,6754,5726,6015,6576,4986,251
Research and development expenses1,0731,2291,760-------5,0395,3634,9775,7185,907
Acquired in-process research and development expenses-------------1,1554,663
In-process research and development impairments------432-820800--2,700504,200
Selling, General and Administrative Expense1,0441,2421,4611,6992,9833,4263,3983,8784,0564,3815,1515,2465,6736,0906,091
Total costs and expenses3,9874,5965,6926,6789,62510,44612,75711,98313,92718,16220,61817,38719,95119,51127,092
Operating income3,9623,7904,0104,52415,26522,19317,63314,1248,2004,2874,0719,9187,3307,6051,662
Interest expense--------------977
Other income (expense)6067-37-931544285236761,868-1,418-639-5811986
Income before income taxes-----------8,2785,8146,859690
Income tax expense1,0248621,0381,1512,7973,5533,6098,8852,339-2041,5802,0771,2481,247211
Net income2,8902,7892,5743,05712,05918,10613,4884,6445,4605,364896,2014,5665,613480
Net loss attributable to noncontrolling interest-1215-18-18-42-2-13165-22-34-24-26-52-
Net income attributable to Gilead2,9012,8042,5923,07512,10118,10813,5014,6445,4605,3861236,2254,5925,665480
Earnings Per Share, Basic3.393.621.712.017.9512.3710.083.544.24.240.14.963.664.540.38
Earnings Per Share, Diluted3.323.551.641.817.3511.919.943.514.174.220.14.933.644.50.38